BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 100778)

  • 41. [Incidence of drug resistance of Mycobacterium tuberculosis].
    Terentieva AS
    Vrach Delo; 1979 Mar; (3):28-30. PubMed ID: 109992
    [No Abstract]   [Full Text] [Related]  

  • 42. [Results of 30 year follow-ups of pulmonary tuberculosis patients contingent with isolated drug resistant or sensitive strains].
    Zhukova MP
    Probl Tuberk; 1997; (5):12-5. PubMed ID: 9454239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The clinical importance of the primary drug resistance of Mycobacterium tuberculosis in destructive forms of pulmonary tuberculosis].
    Khomenko AG; Chesak OI; Biazov TA; Chaikina TN
    Probl Tuberk; 1972; 50(10):28-32. PubMed ID: 4633557
    [No Abstract]   [Full Text] [Related]  

  • 44. [Incidence of primary and secondary resistance of M. tuberculosis in East Germany in 1983 in hospitalized patients].
    Kalich R; Käppler W
    Z Erkr Atmungsorgane; 1986; 167(3):254-60. PubMed ID: 3105189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chemotherapy of tuberculosis--its prerequists, possibilities and limitations].
    Heymer A; Schwabe KH
    Internist (Berl); 1966 Oct; 7(10):502-9. PubMed ID: 4967296
    [No Abstract]   [Full Text] [Related]  

  • 46. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
    Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
    Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M
    Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract]   [Full Text] [Related]  

  • 48. Drug-resistance tuberculosis among the foreign-born in Canada.
    Can Commun Dis Rep; 2005 Feb; 31(4):46-52. PubMed ID: 15712449
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 50. [A study on prevalence of resistance to primary and secondary drugs among newly admitted pulmonary tuberculosis patients in 1977. Part 2. Studies on the factors related to the prevalence of drug resistance (author's transl)].
    Gomi J; Chiba Y; Yanagisawa K
    Kekkaku; 1979 Dec; 54(12):549-55. PubMed ID: 118299
    [No Abstract]   [Full Text] [Related]  

  • 51. [The incidence of primary mycobacterial resistance in the records of the Clinica Tisiologica di Catania].
    Battaglia B
    Arch Monaldi; 1972; 27(4):501-5. PubMed ID: 4217603
    [No Abstract]   [Full Text] [Related]  

  • 52. [The phenomenon of primary mycobacterial resistance in the records of the Clinica Tisiologica di Parma].
    Di Perna A; Rabinovici A
    Arch Monaldi; 1972; 27(4):495-500. PubMed ID: 4217602
    [No Abstract]   [Full Text] [Related]  

  • 53. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
    Nakai H; Maekawa N; Nakanishi M; Kawai M; Naito M
    Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
    [No Abstract]   [Full Text] [Related]  

  • 54. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Epidemiologic aspects of resistance to ATA (Antitubercular Agents)].
    Zrilić V; Muzikravić T
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():29-37. PubMed ID: 4216919
    [No Abstract]   [Full Text] [Related]  

  • 56. [Primary drug resistance in pulmonary tuberculosis (from 1966 till 1975 (author's transl)].
    Kucanda F
    Plucne Bolesti Tuberk; 1977; 29(3-4):229-33. PubMed ID: 416450
    [No Abstract]   [Full Text] [Related]  

  • 57. [Secondary drug resistance of Mycobacterium tuberculosis in chronic destructive forms of pulmonary tuberculosis].
    Poliakova AN; Ianovskaia OM; Samuliak ID; Vasilik GV; Matviĭchuk VM
    Vrach Delo; 1977 Jan; (1):97-9. PubMed ID: 402746
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical, radiological and bacteriological study of pulmonary tuberculosis with bacteria showing drug resistance].
    Albu A; Hartia V; Esrig E; Galbenu M; Marcovici M; Gălculescu A; Golub M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(3):151-60. PubMed ID: 201007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Incidence of primary resistance to antitubercular agents in the Toulouse area].
    Puel J; Galtier M; Lareng MB; Delaude A
    Arch Monaldi; 1972; 27(4):418-25. PubMed ID: 4217598
    [No Abstract]   [Full Text] [Related]  

  • 60. [Fibro-cavernous tuberculosis and its treatment].
    Klebanov MA; Mamolat AS; Butenko GE
    Klin Med (Mosk); 1966 Dec; 44(12):31-8. PubMed ID: 4973178
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.